Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy.
about
Treatment of Chagas cardiomyopathyComprehensive left ventricular mechanics analysis by speckle tracking echocardiography in Chagas disease.Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathyInterferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.Autonomic dysfunction and risk factors associated with Trypanosoma cruzi infection among children in Arequipa, Peru.Mode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial.Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy.Clinical aspects of Chagas disease and implications for novel therapies.Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.Chagas cardiomyopathy and ischemic stroke.The emerging role of MRI in the diagnosis and management of cardiomyopathies.Carlos Chagas Discoveries as a Drop Back to Scientific Construction of Chronic Chagas Heart Disease.Cardiac Magnetic Resonance-Verified Myocardial Fibrosis in Chagas Disease: Clinical Correlates and Risk Stratification.Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy.Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction.Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathyMortality prediction in Chagas heart disease.New diagnostic serum biomarkers for Chagas disease.2 nd Brazilian Consensus on Chagas Disease, 2015.Cardiac magnetic resonance in Chagas' disease.Prognostic Factors in Severe Chagasic Heart Failure.An Infrequent Cause of Apical Ventricular Aneurysm in the United States.Chagas disease: morbidity profile in an endemic area of Northeastern Brazil.Neuromuscular electrical stimulation in a patient with chronic heart failure due to chagas disease: a case report.Prognostic value of exercise-induced ventricular arrhythmia in Chagas' heart disease.Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy.Electrocardiographic ventricular repolarization parameters in chronic Chagas' disease as predictors of asymptomatic left ventricular systolic dysfunction.Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.Urbanization, land tenure security and vector-borne Chagas disease.Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathySudden Cardiac Death in Patients with Chagas Heart Disease and Preserved Left Ventricular Function
P2860
Q26829616-397C97E5-AA4A-410A-A679-1DC81B50DB5BQ30382832-786BCF2D-648E-4DEB-9048-F19B25AF143CQ33955413-2417FD3A-4035-4FDA-80BB-633176F397A3Q34179046-81790D38-C90C-4185-9D61-4B60A3BF3F60Q34422353-40702503-6B99-403C-B234-D5F4F7E8878CQ34702442-29220447-D243-4A04-8BE1-3E6A3AB3E9C7Q34851282-68BBDC98-88A9-4704-90B3-D6C06581A8CBQ34973539-6020C3C1-2A52-4667-AEF5-B33B8DF9DC4DQ35075564-6063F4A0-1734-49AC-A3E6-FC0200E3884AQ35676177-08D5BF6F-EADE-491D-834B-83ABC1195031Q36100436-131F7D2F-A4BF-4B3F-9F17-5C059246B735Q36352043-A119FEEF-B1B8-460F-BFDB-A136008A84F5Q36409266-20D0C8C9-A982-47D1-833D-BDCB02289A4AQ37158632-393585A3-EA87-4597-B7CD-1B2461629C59Q37472908-5AED8A89-7953-44C4-9579-F35120D72270Q37597069-83851184-8C31-407A-BA37-37C25DDB0AEBQ37703783-0C91C787-DF74-4F96-8650-29DE8026C82DQ37781700-33CA1F49-51F8-4450-BA82-73B4D7F4CD04Q38055510-FFC0159B-0E82-4CA8-883D-31D003A1FC08Q38088727-B2959F48-2515-47AF-B21C-3CA0750EE482Q38972541-43288EA8-CCE0-485E-B2D6-A9E2C6101427Q40222901-FC9B1F45-F007-4EFD-BEE7-A214C111B144Q40227676-8FF9E5C8-F00A-4936-967C-FC412A08EC5FQ40957106-6C79D2C3-54BB-467E-B72C-FE7EBE28423FQ41043257-8F3E83AA-53E8-4828-8431-DAED6E24399DQ41846705-BB224B3B-2F06-4D50-9B8F-18E240F56AFEQ42611083-E77BF2AA-A35A-4E09-A9FA-63E7DEABA343Q44953687-E3F8D171-9EE1-47E1-8111-12024755DC10Q45324950-CA341538-371A-4F97-9997-781156FD08C3Q47809586-0C06BDED-B5EB-4DFF-A042-24FD176C75B9Q47883122-9DBA1002-E5A7-45AD-87DC-0B930452EE3CQ51791414-F0CA717B-3477-48DE-8B5E-B56057DB95B1Q52775493-1D25AF9E-35C3-4D19-9B7E-891A2A433138Q58735989-EED90A76-88C0-440B-8119-1F73F59189A0Q58757594-9A5972AB-B9FD-4FAA-90B9-75A1A44B0F2F
P2860
Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Survival and predictors of sur ...... due to Chagas' cardiomyopathy.
@en
type
label
Survival and predictors of sur ...... due to Chagas' cardiomyopathy.
@en
prefLabel
Survival and predictors of sur ...... due to Chagas' cardiomyopathy.
@en
P2093
P356
P1433
P1476
Survival and predictors of sur ...... due to Chagas' cardiomyopathy.
@en
P2093
P304
P356
10.1161/01.CIR.90.6.3098
P407
P577
1994-12-01T00:00:00Z